Abstract
Lung cancer is the principal cause of cancer death worldwide; overall, 5-year survival of patients even with limited disease and resectable tumor is 35–40 %, making lung cancer one of the most important public health problems. Majority of patients die within 2 years of diagnosis. At the time of diagnosis, frequently, the disease is found to have spread beyond the primary site. Early localized lung cancer is treated with surgery with or without adjuvant chemotherapy; patients with positive ipsilateral mediastinal lymphadenopathy are treated with neoadjuvant chemotherapy followed by surgery, while more advanced cases are treated with palliative chemotherapy with or without radiotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
For Further Reading
Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59:78–86.
Buck AK, Herrmann K, Schreyögg J. PET-CT for staging lung cancer: costly or cost-saving? Eur J Nucl Med Mol Imaging. 2011;38:799–801.
De Wever W, Ceyssens S, Mortelmans L, Stroobants S, Marchal G, Bogaert J, et al. Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol. 2007;17:23–32.
Kim SK, Allen Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, et al. Accuracy of PET-CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007;48:214–20.
Lynch TB. Textbook of PET-CT in clinical practice. Springer-Verlag, Berlin/Heidelberg/New York; 2007. p. 16–47.
Mac Manus MP, Hicks RJ. Impact of PET on radiation therapy planning in lung cancer. Radiol Clin North Am. 2007;45:627–38.
Nahmias C, Wahl LM. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med. 2008;49:1804–8.
Yamamoto Y, Kameyama R, Murota M, Bandoh S, Ishii T, Nishiyama Y. Early assessment of therapeutic response using FDG PET in small cell lung cancer. Mol Imaging Biol. 2009;11:467–72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer India
About this chapter
Cite this chapter
Sonavane, S., Basu, S. (2015). PET–CT Imaging of Lung Cancer: The Current Status and Future Potentials. In: Das, B. (eds) Positron Emission Tomography. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2098-5_12
Download citation
DOI: https://doi.org/10.1007/978-81-322-2098-5_12
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2097-8
Online ISBN: 978-81-322-2098-5
eBook Packages: MedicineMedicine (R0)